Precipio Past Earnings Performance
Past criteria checks 0/6
Precipio has been growing earnings at an average annual rate of 20.5%, while the Healthcare industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 30.2% per year.
Key information
20.5%
Earnings growth rate
55.8%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 30.2% |
| Return on equity | -25.1% |
| Net Margin | -17.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Investors Aren't Entirely Convinced By Precipio, Inc.'s (NASDAQ:PRPO) Revenues
Dec 20
Market Might Still Lack Some Conviction On Precipio, Inc. (NASDAQ:PRPO) Even After 29% Share Price Boost
Aug 21Here's Why Shareholders May Want To Be Cautious With Increasing Precipio, Inc.'s (NASDAQ:PRPO) CEO Pay Packet
Jun 07Investors Holding Back On Precipio, Inc. (NASDAQ:PRPO)
Mar 29Precipio, Inc.'s (NASDAQ:PRPO) Subdued P/S Might Signal An Opportunity
Aug 29Precipio to distribute HemeScreen through Fisher Healthcare channel
Jul 20Precipio terminates its equity line with Lincoln Park
Jun 15We Think Some Shareholders May Hesitate To Increase Precipio, Inc.'s (NASDAQ:PRPO) CEO Compensation
Jun 12Precipio shares surge on HemeScreen Anemia Panel launch
Jun 08Precipio shares surge on launching hemescreen panel for Acute Myeloid Leukemia
May 10Precipio: COVID-19 Testing At Amazon Is An Impressive Yet Transitory Fluke
May 05Precipio shares jump on launching its rapid COVID-19 antibody test on Amazon platform
May 03Revenue & Expenses Breakdown
How Precipio makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 17 | -3 | 12 | 0 |
| 30 Jun 24 | 17 | -4 | 12 | 0 |
| 31 Mar 24 | 16 | -5 | 13 | 0 |
| 31 Dec 23 | 15 | -6 | 14 | 0 |
| 30 Sep 23 | 13 | -9 | 14 | 0 |
| 30 Jun 23 | 11 | -11 | 14 | 0 |
| 31 Mar 23 | 10 | -11 | 14 | 0 |
| 31 Dec 22 | 9 | -12 | 15 | 0 |
| 30 Sep 22 | 9 | -12 | 16 | 0 |
| 30 Jun 22 | 9 | -11 | 15 | 0 |
| 31 Mar 22 | 9 | -12 | 15 | 0 |
| 31 Dec 21 | 9 | -9 | 12 | 0 |
| 30 Sep 21 | 8 | -8 | 11 | 0 |
| 30 Jun 21 | 8 | -10 | 11 | 0 |
| 31 Mar 21 | 7 | -9 | 11 | 0 |
| 31 Dec 20 | 6 | -14 | 10 | 0 |
| 30 Sep 20 | 5 | -16 | 10 | 0 |
| 30 Jun 20 | 4 | -14 | 10 | 0 |
| 31 Mar 20 | 4 | -18 | 10 | 0 |
| 31 Dec 19 | 3 | -13 | 10 | 0 |
| 30 Sep 19 | 3 | -16 | 9 | 0 |
| 30 Jun 19 | 3 | -18 | 9 | 0 |
| 31 Mar 19 | 3 | -16 | 9 | 0 |
| 31 Dec 18 | 3 | -20 | 9 | 0 |
| 30 Sep 18 | 3 | -26 | 10 | 0 |
| 30 Jun 18 | 3 | -33 | 10 | 0 |
| 31 Mar 18 | 2 | -38 | 8 | 0 |
| 31 Dec 17 | 2 | -33 | 6 | 0 |
| 30 Sep 17 | 1 | -21 | 5 | 0 |
| 30 Jun 17 | 1 | -11 | 3 | 0 |
| 31 Mar 17 | 1 | -3 | 3 | 0 |
| 31 Dec 16 | 2 | -4 | 2 | 0 |
| 31 Dec 15 | 1 | -2 | 2 | 0 |
Quality Earnings: PRPO is currently unprofitable.
Growing Profit Margin: PRPO is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PRPO is unprofitable, but has reduced losses over the past 5 years at a rate of 20.5% per year.
Accelerating Growth: Unable to compare PRPO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PRPO is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.4%).
Return on Equity
High ROE: PRPO has a negative Return on Equity (-25.12%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 11:44 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Precipio, Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Benjamin Haynor | Alliance Global Partners |
| Jason McCarthy | Maxim Group |